BIOMAT Database Logo BIOMAT Database Logo

Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia. 2002

Ambros Huber, and Lukas Hefler, and Clemens Tempfer, and Harald Zeisler, and Antje Lebrecht, and Peter Husslein
Department of Obstetrics & Gynecology, University of Vienna Medical School, Vienna, Austria.

BACKGROUND Isoforms of transforming growth factor-beta (TGF-beta1) are thought to be involved in the pathogenesis of pre-eclampsia. Data with respect to TGF-beta1 are controversial. We examined the correlation between TGF-beta1 serum levels and the occurrence and severity of pre-eclampsia. METHODS Transforming growth factor-beta 1 serum levels were measured using a commercially available enzyme-linked immunosorbent assay in 44 women with pre-eclampsia and 44 healthy pregnant women. Results were correlated with clinical data. RESULTS No difference in TGF-beta1 serum levels was assessed between women with pre-eclampsia and healthy pregnant women. Transforming growth factor-beta 1 serum levels were not associated with the severity of the disease and were not correlated with clinical maternal (blood pressure, proteinuria) and fetal (5-min APGAR score, umbilical cord pH values, birth weight) parameters. CONCLUSIONS Our data support the assumption that in contrast to other isoforms, TGF-beta1, as evidenced by serum TGF-beta1 levels, does not seem to be involved in the pathogenesis of pre-eclampsia.

UI MeSH Term Description Entries
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011336 Probability The study of chance processes or the relative frequency characterizing a chance process. Probabilities
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence

Related Publications

Ambros Huber, and Lukas Hefler, and Clemens Tempfer, and Harald Zeisler, and Antje Lebrecht, and Peter Husslein
Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia.
May 2002, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
Ambros Huber, and Lukas Hefler, and Clemens Tempfer, and Harald Zeisler, and Antje Lebrecht, and Peter Husslein
Transforming growth factor-beta 1 does not relate to hypertension in pre-eclampsia.
November 2002, Clinical and experimental pharmacology & physiology,
Ambros Huber, and Lukas Hefler, and Clemens Tempfer, and Harald Zeisler, and Antje Lebrecht, and Peter Husslein
Transforming growth factor-beta 1 gene polymorphisms in Korean patients with pre-eclampsia.
April 2010, American journal of reproductive immunology (New York, N.Y. : 1989),
Ambros Huber, and Lukas Hefler, and Clemens Tempfer, and Harald Zeisler, and Antje Lebrecht, and Peter Husslein
Serum transforming growth factor beta 1 levels in multiple myeloma patients.
March 2006, Turkish journal of haematology : official journal of Turkish Society of Haematology,
Ambros Huber, and Lukas Hefler, and Clemens Tempfer, and Harald Zeisler, and Antje Lebrecht, and Peter Husslein
Association between transforming growth factor-beta 1 polymorphisms and risk of pre-eclampsia: a meta-analysis.
December 2022, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
Ambros Huber, and Lukas Hefler, and Clemens Tempfer, and Harald Zeisler, and Antje Lebrecht, and Peter Husslein
Serum Copper Levels in Pregnancy and Pre-Eclampsia.
August 1949, Journal of clinical pathology,
Ambros Huber, and Lukas Hefler, and Clemens Tempfer, and Harald Zeisler, and Antje Lebrecht, and Peter Husslein
Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients.
December 2022, Biomolecules,
Ambros Huber, and Lukas Hefler, and Clemens Tempfer, and Harald Zeisler, and Antje Lebrecht, and Peter Husslein
Serum copper levels in pregnancy and in pre-eclampsia.
August 1949, Journal of clinical pathology,
Ambros Huber, and Lukas Hefler, and Clemens Tempfer, and Harald Zeisler, and Antje Lebrecht, and Peter Husslein
Serum visfatin levels in late pregnancy and pre-eclampsia.
January 2008, Acta obstetricia et gynecologica Scandinavica,
Ambros Huber, and Lukas Hefler, and Clemens Tempfer, and Harald Zeisler, and Antje Lebrecht, and Peter Husslein
'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease.
July 2007, Cardiovascular diabetology,
Copied contents to your clipboard!